Tritiated tryptophan as previously reported (10) was concentrated in the same regions of the liver of MMA mice as described above and in the perifoilicular amyboid deposits of the spleen (Fig. 2) 1 ) and the fibrils depicted in reference 33, Figure  2 , should be noted.
X-ray diffraction studies of coblagenase-treated third layer revealed liver and spleen amyboid to have the following diffraction spacings: a "backbone" spacing at 4.75 A and a "side chain" spacing at 11 A. In addition, these patterns contained a "fat" spacing (removed by cold acetone treatment) at 4.15 A and a spacing of unknown origin at 7.5 A (Fig. 4a ). An x-ray diffraction pattern of human amyboid IV is shown for comparison (Fig.   4b 8) . On Sephadex G-75 or G-100 a single sharp protein peak was obtained ( Fig. 9) . When a crude homogenate of 3H-trypto- on Sephadex G-75, a sharp tritium-labeled fraction was observed although the protein peak was diffuse as compared to that of the SMA liver (Fig. 10) ii. a, peptide map of 5H-tryptophan-labeled MMA spleen 3H peak fractions 37-44 of Sephadex G-100 column (Fig. 10) . b, peptide map of SMA peak fractions 30-35 of Sephadex G-75 column (Fig. 9 ). Tryptophan peptides are circled. and hydroxybysine residues. The NH,-terminal amino acid was unreactive to DNFB and in a separate study was tentatively identified as pyrrobid-2-one-5-carboxylic acid (PCA). Carbohydrate analysis revealed: 6.2% neutral sugars comprising galactose, glucose and an unidentified silver reducing, ninhydrin-unreactive spot moving slower than gabactose in the chromatographic system, presumably an oligosaccharide; 1.2% uronic acid; 0.4% sialic acid; and less than 0.3% hexosamines.
GLENNER
Peptide maps of the incompletely purified MMA splenic (see Fig. 10 ) and purified SMA liver preparations, although revealing a difference in number and intensity of the spots, showed many similar peptides (Fig. 11) . Tryptophan staining of the maps revealed the tryptophan containing peptides to be identical in both. 
DISCUSSION
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